RVNC
Revance Therapeutics, Inc.
Director Mark J Foley bought $539K of Revance Therapeutics, Inc.
Bought$539,168
$26.96Price
20,000Shares
+333%Stake
What RVNC did for a copier
Prices for RVNC after this filing aren't in yet.
Mark J Foley's record
1 other buy on record. A record shows here once 3 of them have 3 months of prices.
We're building an app that can copy buys like this into your own brokerage. Join the waitlist
Traded Tue, Nov 7. Filed Thu, Nov 9, 2:47 PM ET, during the session. Not investment advice.